16 Apasl PPTs View free & download

APASL Consensus on Acute Variceal Bleeding PowerPoint PPT Presentation

APASL Consensus on Acute Variceal Bleeding - Active (Based on endoscopy) 48hr. Vasoactive daugs Therapeutic Endo ... Gold Standard = ENDOSCOPY 3,C. I. Oesophageal Variceal Bleeding ...

Active (Based on endoscopy) 48hr. Vasoactive daugs Therapeutic Endo ... Gold Standard = ENDOSCOPY 3,C. I. Oesophageal Variceal Bleeding ...

| PowerPoint PPT presentation | free to view

APASL Consensus on Acute Variceal Bleeding - Hematemesis within last 24 h of presentation ... Hematemesis / melena or in the minority of patients who have a NG tube in place, ...

Hematemesis within last 24 h of presentation ... Hematemesis / melena or in the minority of patients who have a NG tube in place, ...

| PowerPoint PPT presentation | free to view

Harb Telbivudine Initiatives PowerPoint PPT Presentation

Harb Telbivudine Initiatives - apasl 13 14 15 16 17 easl ...

apasl 13 14 15 16 17 easl ...

| PowerPoint PPT presentation | free to view

Egyptian%20Liver%20Hospital%20ELH PowerPoint PPT Presentation

Egyptian%20Liver%20Hospital%20ELH - Egyptian Liver Hospital ELH ..

Egyptian Liver Hospital ELH ..

| PowerPoint PPT presentation | free to download

Chen C-J, et al. JAMA. 2006;295:65-73; Ganem D -

| PowerPoint PPT presentation | free to view

Robert%20PERRILLO PowerPoint PPT Presentation

Robert%20PERRILLO - PowerPoint-presentatie - PHC ... Robert PERRILLO

PowerPoint-presentatie - PHC ... Robert PERRILLO

| PowerPoint PPT presentation | free to download

Quand peut-on arr PowerPoint PPT Presentation

Quand peut-on arr - Title: Pr sentation PowerPoint - Predicting HCV Therapeutic Outcomes: Can we do better than the 2 log drop model? Author: Administrator Last modified by

Title: Pr sentation PowerPoint - Predicting HCV Therapeutic Outcomes: Can we do better than the 2 log drop model? Author: Administrator Last modified by

| PowerPoint PPT presentation | free to download

bacillary dysentery, shigellosis PowerPoint PPT Presentation

bacillary dysentery, shigellosis - Garten RJ. 8.8. 76.8. 125. Yunnan. ???. HCV HIV. co-infection. HCV HBV. co-infection ... HCV discrimination. Chinese medicines to play an active adjuvant role ...

Garten RJ. 8.8. 76.8. 125. Yunnan. ???. HCV HIV. co-infection. HCV HBV. co-infection ... HCV discrimination. Chinese medicines to play an active adjuvant role ...

| PowerPoint PPT presentation | free to view

HCV; BULAS ve TEDAVI PowerPoint PPT Presentation

HCV; BULAS ve TEDAVI - Usbekistan. Vietnam. Wei ru land. Zaire. ELISA-Befund nach dem 1.1.2004. Afrika. Angola. Arabien. Bali. Belgien. Brasilien. Dominikanische Republik. Estland. Europa ...

Usbekistan. Vietnam. Wei ru land. Zaire. ELISA-Befund nach dem 1.1.2004. Afrika. Angola. Arabien. Bali. Belgien. Brasilien. Dominikanische Republik. Estland. Europa ...

| PowerPoint PPT presentation | free to download

A Personalized Interferon Therapy for Chronic Hepatitis B PowerPoint PPT Presentation

A Personalized Interferon Therapy for Chronic Hepatitis B - Primarily HBeAg-Negative Population IL28B genotypes and HBeAg SC in CHB patients with Peg-IFN in Europe and Asia 57 Impact of Host and Viral Factors on ...

Primarily HBeAg-Negative Population IL28B genotypes and HBeAg SC in CHB patients with Peg-IFN in Europe and Asia 57 Impact of Host and Viral Factors on ...

| PowerPoint PPT presentation | free to view

Evidencebased Treatment for Hepatitis B Infection PowerPoint PPT Presentation

Evidencebased Treatment for Hepatitis B Infection - Liaw et al. Hepatology 1988, Fattovich et al Gut 1991. Risk of HCC increased by 200 folds ... 3. Lok and McMahon Hepatology 2004 (AASLD Guidelines) ...

Liaw et al. Hepatology 1988, Fattovich et al Gut 1991. Risk of HCC increased by 200 folds ... 3. Lok and McMahon Hepatology 2004 (AASLD Guidelines) ...

| PowerPoint PPT presentation | free to view

Viral Hepatitis PowerPoint PPT Presentation

Viral Hepatitis - Hepatology 1998;27:881-886. HAV:Summary ... Hepatology. 2000;31:241-246. Assess severity of necro-inflammation ... Hepatology. 1997;26(suppl 1):72S. (6 mos post ...

Hepatology 1998;27:881-886. HAV:Summary ... Hepatology. 2000;31:241-246. Assess severity of necro-inflammation ... Hepatology. 1997;26(suppl 1):72S. (6 mos post ...

| PowerPoint PPT presentation | free to view

UPDATE on HBV and HCV PowerPoint PPT Presentation

UPDATE on HBV and HCV - Schering, Roche, BMS, Gilead, Pharmasset. Research Grants. Schering, Roche, BMS, Gilead, Pharmasset. Investment position. None. Update ... Gilead Sciences, Inc. ...

Schering, Roche, BMS, Gilead, Pharmasset. Research Grants. Schering, Roche, BMS, Gilead, Pharmasset. Investment position. None. Update ... Gilead Sciences, Inc. ...

| PowerPoint PPT presentation | free to view

Zadaxin - Improved pharmacological profile allows once-weekly dosing ... Chief, Dept of Gastroenterology & Hepatology Principal Investigator ...

Improved pharmacological profile allows once-weekly dosing ... Chief, Dept of Gastroenterology & Hepatology Principal Investigator ...

| PowerPoint PPT presentation | free to view

Nouveaux anti viraux PowerPoint PPT Presentation

Nouveaux anti viraux - Co-r cepteurs CCR5 et CXCR4 pour l'entr e intracellulaire du VIH ... Attachement r versible au CCR5. Pas d'activit sur les virus utilisant CXCR4 (X4) ...

Co-r cepteurs CCR5 et CXCR4 pour l'entr e intracellulaire du VIH ... Attachement r versible au CCR5. Pas d'activit sur les virus utilisant CXCR4 (X4) ...

| PowerPoint PPT presentation | free to view

Estado Actual de la Hepatitis B: Impacto de los Nuevos Tratamientos PowerPoint PPT Presentation

Estado Actual de la Hepatitis B: Impacto de los Nuevos Tratamientos - En Am rica Latina, el impacto de la Hepatitis B es significativo. ... ALT flares. Niveles de HBV DNA. HBeAg cuantitativo. Basal. Intra-Tratamiento ...

En Am rica Latina, el impacto de la Hepatitis B es significativo. ... ALT flares. Niveles de HBV DNA. HBeAg cuantitativo. Basal. Intra-Tratamiento ...

| PowerPoint PPT presentation | free to view

Apasl PowerPoint PPT Presentations